Literature DB >> 10185687

The Allied Health BONE (Best Orthopaedic New Enterprise) team: an interdisciplinary approach to orthopaedic early discharge and admission prevention.

S Brandis1, S Murtagh, R Solia.   

Abstract

This paper presents the conceptual framework, activities and outcomes of the Allied Health BONE (Best Orthopaedic New Enterprise) Team, an early discharge incentive at the Gold Coast Hospital. The clinical team of a physiotherapist, occupational therapist and social worker provided services within an interdisciplinary model of care with the aim of reducing the length of stay of acute adult orthopaedic patients. The team provided intervention in the community, the accident and emergency department, pre-admission clinic and orthopaedic wards to patients with hip and knee replacements, back pain and upper femoral fractures. This paper reports data from the first six months of the project, demonstrating success in improving the continuity of care provided to orthopaedic patients and reducing the length of stay in target groups by 24%.

Entities:  

Mesh:

Year:  1998        PMID: 10185687     DOI: 10.1071/ah980211

Source DB:  PubMed          Journal:  Aust Health Rev        ISSN: 0156-5788            Impact factor:   1.990


  3 in total

Review 1.  Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home.

Authors:  P Mistiaen; E Poot
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

2.  Physiotherapy rehabilitation after total knee or hip replacement: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-06-01

3.  The effect on physical performance of a functional assessment and immediate rehabilitation of acutely admitted elderly patients with reduced functional performance: the design of a randomised clinical trial.

Authors:  Inge Hansen Bruun; Birgitte Nørgaard; Thomas Maribo; Berit Schiøttz-Christensen; Christian Backer Mogensen
Journal:  BMJ Open       Date:  2014-06-17       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.